Impact of an Early Prostate-Specific Antigen Response on Biochemical Progression during Upfront Androgen Receptor Signal Inhibitor Therapy for Metastatic Hormone-Sensitive Prostate Cancer

医学 前列腺特异性抗原 前列腺癌 内科学 肿瘤科 雄激素受体 临床终点 前列腺 泌尿科 雄激素剥夺疗法 癌症 随机对照试验
作者
Asumi Nirazuka,Akinori Nakayama,Minoru Inoue,Hiroki Tsujioka,Keita Izumi,Kiyoshi Setoguchi,Gaku Arai,Kazutaka Saito
出处
期刊:Urologia Internationalis [Karger Publishers]
卷期号:110 (1): 62-68 被引量:1
标识
DOI:10.1159/000546327
摘要

INTRODUCTION: We examined the impact of prostate-specific antigen (PSA) response, which is associated with survival, on patients with metastatic hormone-sensitive prostate cancer (mHSPC) treated with androgen receptor signal inhibitors (ARSIs). METHODS: We retrospectively reviewed 82 patients with mHSPC who received upfront ARSI treatment. The primary endpoint was PSA progression-free survival (PFS). Patients whose PSA levels decreased to ≤0.2 ng/mL at 3 months after ARSI initiation were classified as deep early, those with >0.2-≤1.0 ng/mL as early, and others as non-PSA responders. RESULTS: The median age of patients was 73 years old, and the median baseline PSA value was 361 ng/mL. Among 82 patients, 32 (39%), 16 (20%), and 34 (41%) were categorized into deep early, early, and non-early PSA responders, respectively. There was a significant association between PSA response status, hemoglobin, and PSA value. During follow-up (median, 23.0 months), 31 (37.8%) patients experienced PSA progression. The PSA progression rates of the deep early, early, and non-early PSA responders were 15.6%, 31.2%, and 61.8% (p < 0.001), and their 2-year PSA PFS rates were 90.5%, 70.7%, and 38.9%, respectively. CONCLUSION: An early PSA response within 3 months of ARSI initiation was associated with PSA progression in patients with mHSPC.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
赶紧毕业完成签到,获得积分10
刚刚
张张完成签到 ,获得积分10
1秒前
Mickey完成签到,获得积分10
2秒前
小巧完成签到,获得积分10
2秒前
我是老大的应助被辛夏子采纳,获得10
2秒前
2秒前
3秒前
3秒前
cheveux完成签到,获得积分10
4秒前
空格TNT发布了新的文献求助10
4秒前
JINYUBAO发布了新的文献求助10
4秒前
釜底游鱼完成签到 ,获得积分10
5秒前
鱼鱼完成签到,获得积分10
5秒前
5秒前
愉快夕阳发布了新的文献求助20
5秒前
5秒前
甜美月光的应助被sukuna采纳,获得10
5秒前
123完成签到,获得积分20
5秒前
洁洁完成签到,获得积分10
6秒前
NexusExplorer的应助被俭朴的雨安采纳,获得10
6秒前
6秒前
7秒前
My_magnum_opus给张泽鑫的求助进行了留言
7秒前
chemstation完成签到,获得积分10
7秒前
mf发布了新的文献求助10
7秒前
xpl完成签到,获得积分10
8秒前
打打的应助被sniper采纳,获得10
8秒前
纯真正豪发布了新的文献求助50
9秒前
9秒前
不想说完成签到,获得积分10
10秒前
yunyii发布了新的文献求助30
10秒前
luo发布了新的文献求助10
10秒前
11秒前
大模型的应助被牧羊女采纳,获得10
11秒前
香蕉寒珊发布了新的文献求助10
11秒前
11秒前
jackson98z完成签到 ,获得积分10
12秒前
12秒前
12秒前
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183241
求助须知:如何正确求助?哪些是违规求助? 9572493
关于积分的说明 21826218
捐赠科研通 7780115
什么是DOI,文献DOI怎么找? 3433982
关于科研通互助平台的介绍 2558103
邀请新用户注册赠送积分活动 2480192